![Janet Loesberg](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Janet Loesberg
Direttore Tecnico/Scientifico/R&S presso BLUEPRINT MEDICINES CORPORATION
Posizioni attive di Janet Loesberg
Società | Posizione | Inizio | Fine |
---|---|---|---|
BLUEPRINT MEDICINES CORPORATION | Direttore Tecnico/Scientifico/R&S | 01/03/2020 | - |
AMBRX INC | Direttore/Membro del Consiglio | 01/06/2022 | - |
Ambrx Biopharma, Inc.
![]() Ambrx Biopharma, Inc. BiotechnologyHealth Technology Ambrx Biopharma Cayman, Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA. | Direttore/Membro del Consiglio | 02/06/2022 | - |
Independent Dir/Board Member | - | - | |
All In Together Campaign, Inc. | Direttore/Membro del Consiglio | - | - |
The Loesberg Group LLC | Presidente | - | - |
Storia della carriera di Janet Loesberg
Precedenti posizioni note di Janet Loesberg
Società | Posizione | Inizio | Fine |
---|---|---|---|
Janssen Pharmaceuticals, Inc.
![]() Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Direttore Tecnico/Scientifico/R&S | 01/09/2019 | 01/03/2020 |
Formazione di Janet Loesberg
University of Michigan | Doctorate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 7 |
Isole Cayman | 2 |
Posizioni
Director/Board Member | 4 |
Independent Dir/Board Member | 2 |
Chief Tech/Sci/R&D Officer | 2 |
Settori
Health Technology | 5 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
BLUEPRINT MEDICINES CORPORATION | Health Technology |
Aziende private | 5 |
---|---|
Janssen Pharmaceuticals, Inc.
![]() Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Health Technology |
Ambrx, Inc.
![]() Ambrx, Inc. Pharmaceuticals: MajorHealth Technology Ambrx, Inc. engages in discovering and developing of protein therapeutics. It offers non-native amino acids through expanded genetic code to both generate novel bio-therapeutics. The company was founded by Richard DiMarchi, Peter G. Schultz, and Troy E. Wilson on April 15, 2003 and is headquartered in La Jolla, CA. | Health Technology |
All In Together Campaign, Inc. | |
Ambrx Biopharma, Inc.
![]() Ambrx Biopharma, Inc. BiotechnologyHealth Technology Ambrx Biopharma Cayman, Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA. | Health Technology |
The Loesberg Group LLC |
- Borsa valori
- Insiders
- Janet Loesberg
- Esperienza